US stock futures are showing a higher open, and a number of stocks are in play in pre-market deals.
Biotech and drugs appear to be a focus with Allergan plc (NYSE:AGN) added 1.03% pre-market to US$179.05 despite the botox maker reported a third quarter loss of US$4.03bn, compared to a profit in the same time last year
The results, however, topped Wall Street expectations.
Moleculin Biotech Inc (NASDAQ:MBRX) up 8.81% to US$2.10 ahead of the bell.
It comes as the firm disclosed that MD Anderson filed IND with the FDA for WP1066 for the treatment of brain tumors
Elsewhere, United States Steel Corporation (NYSE:X) added 10.39% to US$27.95 after the firm reported upbeat earnings for its third quarter.
Elsewhere, Abercrombie & Fitch Co (NYSE:ANF) lost 8.79% to US$12.25 each after falling 1.54% yesterday.
Perfume and fashion group Estee Lauder Companies Inc (NYSE:EL) shares zoomed up 8.22% to US$121 after it topped Wall Street expectations for its first quarter.